Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Delek US | DK | Mar 17, 2025 | 16.01 | +2.17 |
Dell Technologies C | DELL | Mar 17, 2025 | 97.66 | +2.08 |
Delta Air Lines | DAL | Mar 17, 2025 | 46.89 | +0.30 |
Deluxe | DLX | Mar 17, 2025 | 16.04 | +1.26 |
Denali Capital Acquisition A | DECA | Mar 17, 2025 | 12.05 | +0.25 |
Denali Therapeutics | DNLI | Mar 17, 2025 | 15.44 | +1.91 |
Denison Mines | DNN | Mar 17, 2025 | 1.45 | +5.07 |
Dennys | DENN | Mar 17, 2025 | 3.92 | -0.25 |
DENTSPLY SIRONA | XRAY | Mar 17, 2025 | 15.59 | +0.19 |
Dermata Therapeutics | DRMA | Mar 17, 2025 | 1.17 | -1.68 |
Descartes Systems Group | DSGX | Mar 17, 2025 | 100.21 | +0.83 |
Design Therapeutics | DSGN | Mar 17, 2025 | 4.93 | +4.78 |
Designer Brands A | DBI | Mar 17, 2025 | 3.71 | +5.70 |
Desktop Metal A | DM | Mar 17, 2025 | 2.75 | +10.44 |
Despegar.com | DESP | Mar 17, 2025 | 19.25 | 0.00 |
Destiny Tech100 | DXYZ | Mar 17, 2025 | 38.99 | +17.09 |
Destra Multialternative Fund | DMA | Mar 17, 2025 | 8.61 | 0.00 |
Deswell Industries | DSWL | Mar 17, 2025 | 2.38 | +1.98 |
Deutsche Bank | DB | Mar 17, 2025 | 23.95 | -1.11 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Mar 17, 2025 | 60.58 | +1.41 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Mar 17, 2025 | 43.36 | +1.50 |
Devon Energy | DVN | Mar 17, 2025 | 35.11 | +1.62 |
DevvStream | DEVS | Mar 17, 2025 | 0.35 | -6.89 |
DexCom | DXCM | Mar 17, 2025 | 71.35 | +0.93 |
DHI Group | DHX | Mar 17, 2025 | 1.73 | +11.61 |
DHT | DHT | Mar 17, 2025 | 10.67 | +1.43 |
Diageo ADR | DEO | Mar 17, 2025 | 109.29 | +1.52 |
DiaMedica Therapeutics | DMAC | Mar 17, 2025 | 5.99 | +3.81 |
Diamond Hill Investment Group A | DHIL | Mar 17, 2025 | 146.28 | +0.33 |
Diamondback Energy | FANG | Mar 17, 2025 | 153.03 | +1.88 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.